A randomized, double-blind, duloxetine-referenced study comparing efficacy and tolerability of 2 fixed doses of vortioxetine in the acute treatment of adults with MDD
Open Access
- 11 January 2015
- journal article
- research article
- Published by Springer Nature in Psychopharmacology
- Vol. 232 (12) , 2061-2070
Abstract
Vortioxetine has reduced depressive symptoms in adults with major depressive disorder (MDD) in multiple clinical trials.Keywords
This publication has 28 references indexed in Scilit:
- Efficacy and safety of vortioxetine (Lu AA21004), 15 and 20 mg/dayInternational Clinical Psychopharmacology, 2014
- Lu AA21004, a novel multimodal antidepressant, produces regionally selective increases of multiple neurotransmitters—A rat microdialysis and electrophysiology studyEuropean Neuropsychopharmacology, 2013
- A Randomized, Double-Blind, Placebo-Controlled 8-Week Trial of the Efficacy and Tolerability of Multiple Doses of Lu AA21004 in Adults With Major Depressive DisorderThe Journal of Clinical Psychiatry, 2012
- A randomized clinical study of Lu AA21004 in the prevention of relapse in patients with major depressive disorderJournal of Psychopharmacology, 2012
- Why Has the Antidepressant–Placebo Difference in Antidepressant Clinical Trials Diminished over the Past Three Decades?CNS Neuroscience & Therapeutics, 2010
- Placebo Response of Non-Pharmacological and Pharmacological Trials in Major Depression: A Systematic Review and Meta-AnalysisPLOS ONE, 2009
- Placebo Response in Randomized Controlled Trials of Antidepressants for Pediatric Major Depressive DisorderAmerican Journal of Psychiatry, 2009
- Acute and Longer-Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D ReportAmerican Journal of Psychiatry, 2006
- Evaluation of Outcomes With Citalopram for Depression Using Measurement-Based Care in STAR*D: Implications for Clinical PracticeAmerican Journal of Psychiatry, 2006
- Sexual Functioning Assessed in 4 Double-Blind Placebo- and Paroxetine-Controlled Trials of Duloxetine for Major Depressive DisorderThe Journal of Clinical Psychiatry, 2005